Trademark: 86587871
Word
VIRTUS
Status
Registered
Status Code
702
Status Date
Friday, September 8, 2023
Serial Number
86587871
Registration Number
5111954
Registration Date
Tuesday, January 3, 2017
Mark Type
4000
Filing Date
Monday, April 6, 2015
Published for Opposition
Tuesday, October 18, 2016

Trademark Owner History
Virtus Pharmaceuticals, LLC - Original Registrant

Classifications
5 Pharmaceuticals, namely, prescription and over-the-counter drugs for the treatment of illness, disease or deficiencies, namely, bacterial infections, treatment symptoms of seasonal, perennial and chronic allergies and the treatment of skin hives and itching associated with skin reactions, Type 2 diabetes mellitus, Treatment and prevention of osteoporosis in postmenopausal women, treatment to increase bone mass in men with osteoporosis, treatment of glucocorticoid induced osteoporosis, Treatment of Paget's Disease of bone, Treatment for the relief of discomfort associated with acute or painful musculoskeletal conditions, Treatment and management of moderate to moderately-severe pain in adults, Treatment of hypertension, Treatment of diabetic nephropathy, Treatment of dermatitis herpetiformis and leprosy, Treatment of chronic inflammatory skin disease marked by blisters, Treatment of acid indigestion, Treatment of upset stomach, Management and support for patients requiring increased folate levels, Supplementation in support of bone health, Supplementation in support of prenatal health, including, without limitation, increased folic acid, Management and support of absorption of calcium and/or functioning of calcium in the body, Treatment of Vitamin D deficiency, Supplementation in support of postnatal health, Treatment and prevention of lack of vitamins, minerals and/or fatty acids during pregnancy, Treatment and temporary relief of cough, nasal congestion, loosening of phlegm and thin bronchial secretions, Treatment and prevention of prenatal and postnatal folate deficiency, Treatment of elevated or high levels of uric acid and prevention and treatment of metabolic problems caused by kidney disease, prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets, hormone replacement therapy, Postnatal supplementation and improvement of nutritional states of women prior to conception, prevention of acidosis, stomach or bowel problems, peptic ulcers and irritable bowel syndrome, Treatment for excessive saliva production, irritable colon and bladder dysfunction, Treatment of symptoms associated with disorders of gastrointestinal tract, bladder spasms, peptic ulcer disease, diverticulitis, irritable bowel syndrome, cystitis and pancreatitis, Prevention and treatment of low blood levels of potassium, Prevention of Fetal Neural Tube Defects when pregnant, Treatment of inadequate folic acid, folate deficiency, and anemia from inadequate folic acid, Treatment of Hyperhomocysteinemia
35 Distributorship services in the field of prescription and over-the-counter drugs; marketing of prescription and over-the-counter drugs
42 Development of pharmaceutical products

Trademark Events
Sep 8, 2023
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Sep 8, 2023
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Sep 8, 2023
Case Assigned To Post Registration Paralegal
Mar 10, 2023
Teas Section 8 & 15 Received
Jan 3, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jan 11, 2017
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 11, 2017
Teas Change Of Owner Address Received
Jan 3, 2017
Registered-Principal Register
Oct 18, 2016
Official Gazette Publication Confirmation E-Mailed
Oct 18, 2016
Published For Opposition
Sep 28, 2016
Notification Of Notice Of Publication E-Mailed
Sep 14, 2016
Law Office Publication Review Completed
Sep 1, 2016
Approved For Pub - Principal Register
Aug 31, 2016
Examiner's Amendment Entered
Aug 31, 2016
Notification Of Examiners Amendment E-Mailed
Aug 31, 2016
Examiners Amendment E-Mailed
Aug 31, 2016
Examiners Amendment -Written
Aug 15, 2016
Teas/Email Correspondence Entered
Aug 15, 2016
Correspondence Received In Law Office
Aug 13, 2016
Assigned To Lie
Aug 5, 2016
Notice Of Revival - E-Mailed
Aug 4, 2016
Teas Response To Office Action Received
Aug 4, 2016
Petition To Revive-Granted
Aug 4, 2016
Teas Petition To Revive Received
Jul 18, 2016
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 18, 2016
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 3, 2016
Notification Of Non-Final Action E-Mailed
Feb 3, 2016
Non-Final Action E-Mailed
Feb 3, 2016
Non-Final Action Written
Jan 20, 2016
Teas/Email Correspondence Entered
Jan 20, 2016
Correspondence Received In Law Office
Jan 20, 2016
Teas Response To Office Action Received
Jul 21, 2015
Notification Of Non-Final Action E-Mailed
Jul 21, 2015
Non-Final Action E-Mailed
Jul 21, 2015
Non-Final Action Written
Jul 20, 2015
Notification Of Non-Final Action E-Mailed
Jul 20, 2015
Non-Final Action E-Mailed
Jul 20, 2015
Non-Final Action Written
Jul 14, 2015
Assigned To Examiner
Apr 30, 2015
Teas Amendment Entered Before Attorney Assigned
Apr 30, 2015
Teas Voluntary Amendment Received
Apr 14, 2015
New Application Office Supplied Data Entered
Apr 9, 2015
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24